Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 7.699.312 | 427.101 | 2 | ||
2010 | 0 | 23.820.054 | 3.424.226 | 4 |
Total number of partners: 1175
Partner loyalty:
Frequent Partner: (> 2 projects): 406
Rare Partner: 769
Frequent / Rare Partner Ratio: 0.53
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-01-01 | HEPATIC MICROFLUIDIC BIOREACTOR | HeMiBio | participant | 4.700.000 | 13 |
2011-01-01 | Developing and Evaluating Communication strategies to support Informed Decisions and practice based on Evidence | DECIDE | participant | 2.999.312 | 13 |
2010-11-01 | Host and viral factors in acute hepatitis C | HepaCute | participant | 2.999.500 | 17 |
2010-10-01 | Development of novel antiviral drugs against Influenza | FLUCURE | participant | 5.982.600 | 10 |
2010-01-01 | Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer | EpiDiaCan | participant | 2.843.859 | 7 |
2010-01-01 | NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE | TRANSEURO | participant | 11.994.095 | 15 |